- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03382223
Panel Study Investigating Status of Cognitively Impaired Elderly in Singapore (PISCES)
Dementia affects 10% of the elderly population in Singapore. However, there is a lack of systematic information regarding end of life (EOL) care received by patients dying with severe dementia (PDSD), PDSD's EOL direct and indirect costs and caregiver burden. This study, a first of-its-kind prospective cohort study in Singapore will assess the EOL care received by PDSD and PDSD's caregivers, EOL medical and social care costs of severe dementia and caregiver burden; and will develop a risk score to predict 6-month mortality for PDSD. The investigators will accomplish this by surveying caregivers of PDSD every 4 months till the patient passes away and 6 weeks and 6 months after patient's death during caregiver bereavement. The investigators will also extract and match patient medical and billing data with survey data for comprehensive assessment of care costs.
Key outcomes achieved by this study will be improved understanding of PDSD's EOL care, EOL care costs, and caregiver burden and bereavement. The systematic data collected will also lead to predicting 6 month mortality for community dwelling PDSD with greater accuracy compared to existing tools. Positive implications from this study will be improved early decision making by caregivers regarding EOL care and physician referrals for palliative care services; and a better understanding of EOL care for PDSD and PDSD's caregivers that will lead to cross-sector collaborations to improve delivery of palliative care to PDSD. In this way this proposal is highly responsive to the grant call which focuses on early decision making and cross sector palliative care delivery among non-cancer patients. In the long term, this study will improve clinical and public health policy and has the potential to be the foundation for future initiatives for dementia care and improved social and medical infrastructure planning.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Singapore, Singapore, 169608
- Singapore General Hospital
-
Singapore, Singapore, 529889
- Changi General Hospital
-
Singapore, Singapore, 768828
- Khoo Teck Puat Hospital
-
Singapore, Singapore, 539747
- Institute of Mental Health
-
Singapore, Singapore, 609606
- Jurong Community Hospital
-
Singapore, Singapore, 168730
- Tsao Foundation
-
Singapore, Singapore, 339940
- Alzheimer's Disease Association
-
Singapore, Singapore, 427411
- Care for the Elderly Foundation
-
Singapore, Singapore, 659674
- St. Luke's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria for primary informal caregivers are:
- Age ≥ 21 years old
- Singaporean/Singapore Permanent Resident
- Intact cognition determined through the Abbreviated Mental Test (AMT) for those who are ≥ 65 years old
- Patients who score 20 or more on QDRS answered by caregivers will be considered to have severe dementia
- Main person or one of the main persons providing care to patient (e.g. accompanying patient for doctor's visits, helping patient with day to day activities)
- Main person or one of the main persons ensuring the provision of care to patient (e.g. supervision of foreign domestic worker so that patient is looked after)
- Main person or one of the main persons involved in making decisions regarding treatment patient receives
Exclusion Criteria for primary informal caregivers are:
- Caregivers ≥ 65 years old with cognitive impairment or serious mental illness determined through AMT
- Foreign domestic workers/maids
Inclusion Criteria for physicians are:
(a) Caregivers of patients they are treating are enrolled in the study
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in quality of life of patient
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess the quality of life of patient by asking caregivers the list of comorbidities and acute medical conditions that patient has, patient's experience of symptoms, patient's functional status and behaviours that patient exhibits.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in quality of care received by patient
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess the quality of care received by patient by asking the caregiver of any use of tube-feeding, physical restraint and other medical interventions; as well as checking with the caregiver if they are satisfied with the care provided for patient.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in caregiver's resilience
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess caregiver's resilience through the abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC 2. Only 2 items will be adapted from CD-RISC.
For each item, it is rated on a 5-point scale, ranging from 0 to 4 as follows: "not true at all", "rarely true", "sometimes true", "often true" and "true nearly all of the time", with higher scores reflecting greater resilience.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in caregiver burden
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess caregiver burden through modified Caregiver Reaction Assessment (CRA) Instrument.
This instrument captures 5 domains of caregiver reaction and we adopted 4 out of the 5 domains.
Each item is scored on a five-point likert scale, ranging from 0 to 4 as follows: "strongly disagree", "disagree", "neither agree nor disagree", "agree" and "strongly agree".
We amended and included "not applicable" to the scale as well.
The items constituting a particular domain are averaged to generate subscale scores.
A higher score on the subscales indicate greater negative effects of caregiving in those domains.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in caregiver's ability to cope
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess caregiver's ability to cope through the BriefCOPE instrument.
This instrument measures 14 conceptually differentiable coping reactions; each of which comprises of 2 subscales.
The scale ranges from 0 to 3 as follows: "I haven't been doing this at all", "I've been doing this a little bit", "I've been doing this a medium amount" and "I've been doing this a lot".
This measure does not compute the overall score.
The scales are analysed separately to see what its relation is to other variables.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in caregiver's levels of emotional distress
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess caregiver's anxiety and depression through the Hospital Anxiety and Depression Scale (HADS).
The instrument comprises seven questions for anxiety and seven questions for depression.
Each item comprises of a four point (0-3) response category.
Hence the possible score ranges from 0 to 21 for anxiety and for depression.
A score of 0 to 7 for either subscale is regarded as being in the normal range, a score of 11 or higher indicates probable presence of mood disorder and a score of 8 to 10 is suggestive of the presence of the respective state.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in caregiver's awareness of prognostic information
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess preferences of caregivers for the disclosure of prognostic information of patient.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in caregiver's grief experience
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess caregiver's grief experience through the MM Caregiver Grief Inventory- Short Form (MM-CGI-SF).
The instrument consists of 3 domains (each domain has 6 items) with a total of 18 items.
For each item, the scale ranges from 1 to 5 as follows: "strongly disagree", "disagree", "somewhat agree", "agree" and "strongly agree".
The subscale is computed by summing up the scores of the 6 items for each domain.
Higher scores may indicate a need for formal intervention or support assistance to enhance coping, while lower scores may indicate denial or a downplaying of distress or positive adaptation if the individual is not showing other signs of suppressed grief.
The total grief level is computed by summing up the scores for the 18 items.The higher the score, the greater the level of grief experienced by the caregiver, vice versa.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Change in resource utilisation for patient
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will assess the healthcare resource utilisation of patient and caregiver through modified Resource Utilisation in Dementia Lite (RUD-Lite) Instrument.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
|
Total healthcare expenditure during the last year of life through analysis of medical bills
Time Frame: From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
We will calculate total healthcare expenditure during the last year of patient's life as the sum total of expenditures incurred at in-patient clinics, out-patient clinics, and visits to emergency department and on prescription drugs.
|
From recruitment to death of patient (baseline, 4 month, 8 month, 12 month, 16 month, 20 month, 24 month)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Caregiver's perception of patient's quality of life at end-of-life, assessed after patient's death
Time Frame: 6 weeks bereavement
|
We will assess caregiver's perception of patient's end-of-life care after patient's death through the Satisfaction With Care at the End of Life in Dementia (SWC-EOLD) scale.
The scale has 10 items, each measured on a 4-point likert scale ranging from 1 to 4 as follows: "strongly disagree", "disagree", "agree", "strongly agree".
The total SWC-EOLD score is computed by the summation of all 10 items (range of 10 to 40), with higher scores indicating more satisfaction.
|
6 weeks bereavement
|
|
Caregiver's bereavement adjustment
Time Frame: 6 months bereavement
|
Post-patient death bereavement adjustment will be assessed through the Brief Grief Questionnaire.
This is a 5-item interview instrument for screening complicated grief.
For each item, the scale ranges from 0 to 2 as follows: "not at all", "somewhat" and "a lot".
The total score is computed by summing up the score for each item.
If the total score is 5 or more, it may be suggestive of the presence of the syndrome of complicated grief.
|
6 months bereavement
|
|
Cultural stigma associated with dementia
Time Frame: Up to 6 months post-bereavement
|
We will assess the cultural stigma associated with dementia by asking in-depth questions such as caregiver's perception of dementia before and after patient's diagnosis, caregiver's experience of outsiders' responses and attitudes towards dementia and how physicians give the diagnosis of dementia.
|
Up to 6 months post-bereavement
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Chetna Malhotra, MD, MPH, Lien Centre for Palliative Care/Duke-NUS Medical School
Publications and helpful links
General Publications
- Malhotra C, Vishwanath P, Yong JR, Ostbye T, Seow D, Yap P, Tan LL, Tham WY, Vaingankar J, Foo J, Tan BY, Tong K, Ng WC, Allen JC Jr, Malhotra R, Tan WM, Wee SL, Ng LL, Goveas R, Mok V, Sim A, Ng WF, Wong HK, Balasundaram B, Tan RQ, Ong PS, Cheong CY, Yee Chung Pheng A, Tiong C, Hum A, Lee A, Finkelstein EA. A Prospective Longitudinal Study of Caregivers of Community Dwelling Persons with Severe Dementia (PISCES): Study Protocol. J Alzheimers Dis. 2020;75(2):403-416. doi: 10.3233/JAD-190897.
- Malhotra C, Chaudhry I, Shah SU, Ostbye T, Malhotra R. Trajectories of negative and positive experiences of caregiving for older adults with severe dementia: application of group-based multi-trajectory modelling. BMC Geriatr. 2024 Feb 19;24(1):172. doi: 10.1186/s12877-024-04777-w.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017/2989
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Advanced Dementia
-
Yaolin PeiNational Institutes of Health (NIH)RecruitingEnd of Life Decision Making | Dementia Caregivers | Advanced DementiaUnited States
-
Hebrew SeniorLifeNational Institutes of Health (NIH); National Institute on Aging (NIA)CompletedAdvanced DementiaUnited States
-
Technical University of MunichBavarian State Ministry of Health and Care; German Alzheimer SocietyCompleted
-
Ralf J. JoxCompletedAdvanced Dementia | Loss of Medical Decision Making CapacitySwitzerland
-
Technical University of MunichGerman Federal Ministry of Education and Research; Centre Hospitalier Universitaire... and other collaboratorsCompletedPalliative Care | Advanced Dementia StagesGermany
-
Oregon Health and Science UniversityUniversity of PennsylvaniaCompletedDementia | Advanced Care PlanningUnited States
-
University of ChicagoNational Institute on Aging (NIA); University of North Carolina, Chapel HillCompletedDementia | Hip Pain | Emergency Department Patient | Pain in Advanced Dementia ScaleUnited States
-
Wake Forest University Health SciencesNational Institute on Aging (NIA)CompletedAdvanced Care PlanningUnited States
-
Benjamin Rose Institute on AgingNational Institute on Aging (NIA)RecruitingMild Dementia | Moderate DementiaUnited States
-
Amsterdam UMC, location VUmcCompletedColorectum Advanced Malignancies | Breast Advanced Malignancies | Prostate Advanced MalignanciesNetherlands